Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

4teen4 Pharmaceuticals Gmbh

Clinical trials sponsored by 4teen4 Pharmaceuticals Gmbh, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody drug targets deadly heart shock in early trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New antibody drug targets deadly heart shock in early trial

Disease control Recruiting now

This early-stage trial tests a new antibody drug called procizumab in 130 people with cardiogenic shock, a life-threatening condition where the heart cannot pump enough blood. The drug blocks a protein called DPP3, which is linked to worse outcomes. The main goal is to check safe…

Phase 1/2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC